Socati CEO to Address FDA Hearing, Call on Agency to Provide Regulatory Framework to Unleash CBD Industry Growth

  • Socati CEO Josh Epstein picked from among hundreds of applicants to speak at first FDA hearing to regulate products containing, derived from hemp
  • Selection comes as Socati ramps up production of high-quality broad-spectrum hemp extracts after acquiring large-scale processing facility

WOODBURN, Ore.–(BUSINESS WIRE)–Socati Corp., a leading manufacturer of broad-spectrum hemp extract, announced today that CEO Josh Epstein has been selected from among hundreds of applicants to speak at the Food and Drug Administration’s (FDA) first public hearing on hemp-derived compounds. The FDA is seeking industry responses as it evaluates regulatory pathways for products containing and derived from hemp, including CBD.

Read the full release.